nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Ibuprofen—Melphalan—ovarian cancer	0.756	1	CrCrCtD
Esmolol—Ibuprofen—CXCL8—ovarian cancer	0.000867	0.304	CrCbGaD
Esmolol—Atenolol—ABCB1—ovarian cancer	0.000481	0.169	CrCbGaD
Esmolol—Acebutolol—ABCB1—ovarian cancer	0.000444	0.156	CrCbGaD
Esmolol—Pulmonary oedema—Epirubicin—ovarian cancer	0.000435	0.0018	CcSEcCtD
Esmolol—Anorexia—Vinorelbine—ovarian cancer	0.000432	0.00179	CcSEcCtD
Esmolol—Skin exfoliation—Doxorubicin—ovarian cancer	0.000431	0.00179	CcSEcCtD
Esmolol—Rhinitis—Paclitaxel—ovarian cancer	0.00043	0.00178	CcSEcCtD
Esmolol—Asthenia—Chlorambucil—ovarian cancer	0.000427	0.00177	CcSEcCtD
Esmolol—Abnormal vision—Epirubicin—ovarian cancer	0.000426	0.00176	CcSEcCtD
Esmolol—Pharyngitis—Paclitaxel—ovarian cancer	0.000426	0.00176	CcSEcCtD
Esmolol—Neuropathy—Doxorubicin—ovarian cancer	0.000424	0.00176	CcSEcCtD
Esmolol—Mental disability—Epirubicin—ovarian cancer	0.000424	0.00176	CcSEcCtD
Esmolol—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000424	0.00176	CcSEcCtD
Esmolol—Hypotension—Vinorelbine—ovarian cancer	0.000423	0.00175	CcSEcCtD
Esmolol—Pruritus—Chlorambucil—ovarian cancer	0.000421	0.00174	CcSEcCtD
Esmolol—Urticaria—Topotecan—ovarian cancer	0.000421	0.00174	CcSEcCtD
Esmolol—Urethral disorder—Paclitaxel—ovarian cancer	0.000421	0.00174	CcSEcCtD
Esmolol—Body temperature increased—Topotecan—ovarian cancer	0.000419	0.00173	CcSEcCtD
Esmolol—Visual impairment—Paclitaxel—ovarian cancer	0.000413	0.00171	CcSEcCtD
Esmolol—Urticaria—Melphalan—ovarian cancer	0.000412	0.00171	CcSEcCtD
Esmolol—Thrombophlebitis—Epirubicin—ovarian cancer	0.00041	0.0017	CcSEcCtD
Esmolol—Ecchymosis—Doxorubicin—ovarian cancer	0.000409	0.00169	CcSEcCtD
Esmolol—Paraesthesia—Vinorelbine—ovarian cancer	0.000407	0.00169	CcSEcCtD
Esmolol—Dyspnoea—Vinorelbine—ovarian cancer	0.000404	0.00167	CcSEcCtD
Esmolol—Pulmonary oedema—Doxorubicin—ovarian cancer	0.000402	0.00167	CcSEcCtD
Esmolol—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000399	0.00165	CcSEcCtD
Esmolol—Flushing—Paclitaxel—ovarian cancer	0.000398	0.00165	CcSEcCtD
Esmolol—Cardiac disorder—Paclitaxel—ovarian cancer	0.000398	0.00165	CcSEcCtD
Esmolol—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000397	0.00164	CcSEcCtD
Esmolol—Myocardial infarction—Docetaxel—ovarian cancer	0.000397	0.00164	CcSEcCtD
Esmolol—Abnormal vision—Doxorubicin—ovarian cancer	0.000394	0.00163	CcSEcCtD
Esmolol—Decreased appetite—Vinorelbine—ovarian cancer	0.000394	0.00163	CcSEcCtD
Esmolol—Mental disability—Doxorubicin—ovarian cancer	0.000392	0.00162	CcSEcCtD
Esmolol—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000391	0.00162	CcSEcCtD
Esmolol—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000391	0.00162	CcSEcCtD
Esmolol—Fatigue—Vinorelbine—ovarian cancer	0.000391	0.00162	CcSEcCtD
Esmolol—Angiopathy—Paclitaxel—ovarian cancer	0.000389	0.00161	CcSEcCtD
Esmolol—Pain—Vinorelbine—ovarian cancer	0.000387	0.00161	CcSEcCtD
Esmolol—Constipation—Vinorelbine—ovarian cancer	0.000387	0.00161	CcSEcCtD
Esmolol—Chills—Paclitaxel—ovarian cancer	0.000385	0.00159	CcSEcCtD
Esmolol—Asthenia—Topotecan—ovarian cancer	0.00038	0.00157	CcSEcCtD
Esmolol—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000379	0.00157	CcSEcCtD
Esmolol—Vomiting—Chlorambucil—ovarian cancer	0.000378	0.00157	CcSEcCtD
Esmolol—Mental disorder—Paclitaxel—ovarian cancer	0.000376	0.00156	CcSEcCtD
Esmolol—Metoprolol—ABCB1—ovarian cancer	0.000375	0.132	CrCbGaD
Esmolol—Pruritus—Topotecan—ovarian cancer	0.000375	0.00155	CcSEcCtD
Esmolol—Erythema—Paclitaxel—ovarian cancer	0.000373	0.00155	CcSEcCtD
Esmolol—Feeling abnormal—Vinorelbine—ovarian cancer	0.000373	0.00155	CcSEcCtD
Esmolol—Asthenia—Melphalan—ovarian cancer	0.000372	0.00154	CcSEcCtD
Esmolol—Dermatitis bullous—Epirubicin—ovarian cancer	0.000371	0.00154	CcSEcCtD
Esmolol—Pruritus—Melphalan—ovarian cancer	0.000367	0.00152	CcSEcCtD
Esmolol—Dysgeusia—Paclitaxel—ovarian cancer	0.000366	0.00151	CcSEcCtD
Esmolol—Rhinitis—Docetaxel—ovarian cancer	0.000365	0.00151	CcSEcCtD
Esmolol—Cardiac failure—Epirubicin—ovarian cancer	0.000363	0.0015	CcSEcCtD
Esmolol—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000362	0.0015	CcSEcCtD
Esmolol—Pharyngitis—Docetaxel—ovarian cancer	0.000361	0.0015	CcSEcCtD
Esmolol—Urticaria—Vinorelbine—ovarian cancer	0.00036	0.00149	CcSEcCtD
Esmolol—Urinary tract disorder—Docetaxel—ovarian cancer	0.000359	0.00149	CcSEcCtD
Esmolol—Body temperature increased—Vinorelbine—ovarian cancer	0.000358	0.00148	CcSEcCtD
Esmolol—Urethral disorder—Docetaxel—ovarian cancer	0.000356	0.00148	CcSEcCtD
Esmolol—Nausea—Chlorambucil—ovarian cancer	0.000353	0.00146	CcSEcCtD
Esmolol—Visual impairment—Docetaxel—ovarian cancer	0.00035	0.00145	CcSEcCtD
Esmolol—Dizziness—Topotecan—ovarian cancer	0.00035	0.00145	CcSEcCtD
Esmolol—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000343	0.00142	CcSEcCtD
Esmolol—Agitation—Paclitaxel—ovarian cancer	0.000343	0.00142	CcSEcCtD
Esmolol—Angioedema—Paclitaxel—ovarian cancer	0.000341	0.00141	CcSEcCtD
Esmolol—Flushing—Docetaxel—ovarian cancer	0.000337	0.0014	CcSEcCtD
Esmolol—Cardiac disorder—Docetaxel—ovarian cancer	0.000337	0.0014	CcSEcCtD
Esmolol—Cardiac arrest—Epirubicin—ovarian cancer	0.000337	0.0014	CcSEcCtD
Esmolol—Vomiting—Topotecan—ovarian cancer	0.000337	0.0014	CcSEcCtD
Esmolol—Cardiac failure—Doxorubicin—ovarian cancer	0.000336	0.00139	CcSEcCtD
Esmolol—Syncope—Paclitaxel—ovarian cancer	0.000335	0.00139	CcSEcCtD
Esmolol—Headache—Topotecan—ovarian cancer	0.000332	0.00137	CcSEcCtD
Esmolol—Angiopathy—Docetaxel—ovarian cancer	0.00033	0.00137	CcSEcCtD
Esmolol—Vomiting—Melphalan—ovarian cancer	0.00033	0.00137	CcSEcCtD
Esmolol—Loss of consciousness—Paclitaxel—ovarian cancer	0.000328	0.00136	CcSEcCtD
Esmolol—Chills—Docetaxel—ovarian cancer	0.000326	0.00135	CcSEcCtD
Esmolol—Asthenia—Vinorelbine—ovarian cancer	0.000325	0.00135	CcSEcCtD
Esmolol—Convulsion—Paclitaxel—ovarian cancer	0.000324	0.00134	CcSEcCtD
Esmolol—Pruritus—Vinorelbine—ovarian cancer	0.000321	0.00133	CcSEcCtD
Esmolol—Mental disorder—Docetaxel—ovarian cancer	0.000319	0.00132	CcSEcCtD
Esmolol—Chest pain—Paclitaxel—ovarian cancer	0.000318	0.00132	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—ovarian cancer	0.000317	0.00131	CcSEcCtD
Esmolol—Anxiety—Paclitaxel—ovarian cancer	0.000317	0.00131	CcSEcCtD
Esmolol—Erythema—Docetaxel—ovarian cancer	0.000317	0.00131	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000316	0.00131	CcSEcCtD
Esmolol—Nausea—Topotecan—ovarian cancer	0.000315	0.0013	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—ovarian cancer	0.000312	0.00129	CcSEcCtD
Esmolol—Dry mouth—Paclitaxel—ovarian cancer	0.000311	0.00129	CcSEcCtD
Esmolol—Dysgeusia—Docetaxel—ovarian cancer	0.00031	0.00128	CcSEcCtD
Esmolol—Nausea—Melphalan—ovarian cancer	0.000308	0.00128	CcSEcCtD
Esmolol—Confusional state—Paclitaxel—ovarian cancer	0.000307	0.00127	CcSEcCtD
Esmolol—Oedema—Paclitaxel—ovarian cancer	0.000305	0.00126	CcSEcCtD
Esmolol—Shock—Paclitaxel—ovarian cancer	0.0003	0.00124	CcSEcCtD
Esmolol—Dizziness—Vinorelbine—ovarian cancer	0.0003	0.00124	CcSEcCtD
Esmolol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000299	0.00124	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—ovarian cancer	0.000298	0.00124	CcSEcCtD
Esmolol—Skin disorder—Paclitaxel—ovarian cancer	0.000296	0.00123	CcSEcCtD
Esmolol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000295	0.00122	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000293	0.00122	CcSEcCtD
Esmolol—Anorexia—Paclitaxel—ovarian cancer	0.000291	0.0012	CcSEcCtD
Esmolol—Vomiting—Vinorelbine—ovarian cancer	0.000288	0.00119	CcSEcCtD
Esmolol—Dysuria—Epirubicin—ovarian cancer	0.000287	0.00119	CcSEcCtD
Esmolol—Hypotension—Paclitaxel—ovarian cancer	0.000285	0.00118	CcSEcCtD
Esmolol—Headache—Vinorelbine—ovarian cancer	0.000284	0.00118	CcSEcCtD
Esmolol—Syncope—Docetaxel—ovarian cancer	0.000284	0.00118	CcSEcCtD
Esmolol—Loss of consciousness—Docetaxel—ovarian cancer	0.000278	0.00115	CcSEcCtD
Esmolol—Propafenone—ABCB1—ovarian cancer	0.000277	0.0971	CrCbGaD
Esmolol—Angina pectoris—Doxorubicin—ovarian cancer	0.000276	0.00114	CcSEcCtD
Esmolol—Convulsion—Docetaxel—ovarian cancer	0.000274	0.00114	CcSEcCtD
Esmolol—Paraesthesia—Paclitaxel—ovarian cancer	0.000274	0.00113	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—ovarian cancer	0.000273	0.00113	CcSEcCtD
Esmolol—Dyspnoea—Paclitaxel—ovarian cancer	0.000272	0.00113	CcSEcCtD
Esmolol—Somnolence—Paclitaxel—ovarian cancer	0.000271	0.00112	CcSEcCtD
Esmolol—Chest pain—Docetaxel—ovarian cancer	0.000269	0.00112	CcSEcCtD
Esmolol—Nausea—Vinorelbine—ovarian cancer	0.000269	0.00112	CcSEcCtD
Esmolol—Dyspepsia—Paclitaxel—ovarian cancer	0.000268	0.00111	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000268	0.00111	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000268	0.00111	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—ovarian cancer	0.000265	0.0011	CcSEcCtD
Esmolol—Decreased appetite—Paclitaxel—ovarian cancer	0.000265	0.0011	CcSEcCtD
Esmolol—Dry mouth—Docetaxel—ovarian cancer	0.000264	0.00109	CcSEcCtD
Esmolol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000263	0.00109	CcSEcCtD
Esmolol—Fatigue—Paclitaxel—ovarian cancer	0.000263	0.00109	CcSEcCtD
Esmolol—Pain—Paclitaxel—ovarian cancer	0.000261	0.00108	CcSEcCtD
Esmolol—Constipation—Paclitaxel—ovarian cancer	0.000261	0.00108	CcSEcCtD
Esmolol—Confusional state—Docetaxel—ovarian cancer	0.00026	0.00108	CcSEcCtD
Esmolol—Oedema—Docetaxel—ovarian cancer	0.000258	0.00107	CcSEcCtD
Esmolol—Shock—Docetaxel—ovarian cancer	0.000254	0.00105	CcSEcCtD
Esmolol—Nervous system disorder—Docetaxel—ovarian cancer	0.000253	0.00105	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—ovarian cancer	0.000253	0.00105	CcSEcCtD
Esmolol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000251	0.00104	CcSEcCtD
Esmolol—Skin disorder—Docetaxel—ovarian cancer	0.000251	0.00104	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—ovarian cancer	0.00025	0.00103	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000248	0.00103	CcSEcCtD
Esmolol—Anorexia—Docetaxel—ovarian cancer	0.000246	0.00102	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—ovarian cancer	0.000246	0.00102	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—ovarian cancer	0.000243	0.00101	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—ovarian cancer	0.000242	0.001	CcSEcCtD
Esmolol—Urticaria—Paclitaxel—ovarian cancer	0.000242	0.001	CcSEcCtD
Esmolol—Hypotension—Docetaxel—ovarian cancer	0.000241	0.001	CcSEcCtD
Esmolol—Body temperature increased—Paclitaxel—ovarian cancer	0.000241	0.000998	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—ovarian cancer	0.00024	0.000996	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—ovarian cancer	0.000236	0.000979	CcSEcCtD
Esmolol—Paraesthesia—Docetaxel—ovarian cancer	0.000232	0.000961	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—ovarian cancer	0.000231	0.000957	CcSEcCtD
Esmolol—Dyspnoea—Docetaxel—ovarian cancer	0.00023	0.000954	CcSEcCtD
Esmolol—Somnolence—Docetaxel—ovarian cancer	0.00023	0.000951	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—ovarian cancer	0.000228	0.000943	CcSEcCtD
Esmolol—Flushing—Epirubicin—ovarian cancer	0.000228	0.000943	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—ovarian cancer	0.000227	0.000942	CcSEcCtD
Esmolol—Dyspepsia—Docetaxel—ovarian cancer	0.000227	0.000942	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—ovarian cancer	0.000225	0.000933	CcSEcCtD
Esmolol—Decreased appetite—Docetaxel—ovarian cancer	0.000225	0.00093	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000224	0.000928	CcSEcCtD
Esmolol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000223	0.000924	CcSEcCtD
Esmolol—Fatigue—Docetaxel—ovarian cancer	0.000223	0.000923	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—ovarian cancer	0.000223	0.000922	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—ovarian cancer	0.000222	0.000922	CcSEcCtD
Esmolol—Pain—Docetaxel—ovarian cancer	0.000221	0.000915	CcSEcCtD
Esmolol—Constipation—Docetaxel—ovarian cancer	0.000221	0.000915	CcSEcCtD
Esmolol—Chills—Epirubicin—ovarian cancer	0.00022	0.000912	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—ovarian cancer	0.000219	0.000906	CcSEcCtD
Esmolol—Asthenia—Paclitaxel—ovarian cancer	0.000219	0.000906	CcSEcCtD
Esmolol—Pruritus—Paclitaxel—ovarian cancer	0.000216	0.000893	CcSEcCtD
Esmolol—Ibuprofen—ABCB1—ovarian cancer	0.000215	0.0755	CrCbGaD
Esmolol—Mental disorder—Epirubicin—ovarian cancer	0.000215	0.00089	CcSEcCtD
Esmolol—Erythema—Epirubicin—ovarian cancer	0.000213	0.000884	CcSEcCtD
Esmolol—Feeling abnormal—Docetaxel—ovarian cancer	0.000213	0.000882	CcSEcCtD
Esmolol—Flushing—Doxorubicin—ovarian cancer	0.000211	0.000872	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—ovarian cancer	0.000211	0.000872	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—ovarian cancer	0.000209	0.000866	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—ovarian cancer	0.000206	0.000853	CcSEcCtD
Esmolol—Body temperature increased—Docetaxel—ovarian cancer	0.000204	0.000846	CcSEcCtD
Esmolol—Chills—Doxorubicin—ovarian cancer	0.000204	0.000844	CcSEcCtD
Esmolol—Dizziness—Paclitaxel—ovarian cancer	0.000202	0.000835	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—ovarian cancer	0.000199	0.000824	CcSEcCtD
Esmolol—Erythema—Doxorubicin—ovarian cancer	0.000198	0.000818	CcSEcCtD
Esmolol—Agitation—Epirubicin—ovarian cancer	0.000196	0.000813	CcSEcCtD
Esmolol—Vomiting—Paclitaxel—ovarian cancer	0.000194	0.000803	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—ovarian cancer	0.000193	0.000801	CcSEcCtD
Esmolol—Syncope—Epirubicin—ovarian cancer	0.000191	0.000793	CcSEcCtD
Esmolol—Headache—Paclitaxel—ovarian cancer	0.000191	0.000791	CcSEcCtD
Esmolol—Propranolol—ABCB1—ovarian cancer	0.000189	0.0665	CrCbGaD
Esmolol—Loss of consciousness—Epirubicin—ovarian cancer	0.000188	0.000777	CcSEcCtD
Esmolol—Asthenia—Docetaxel—ovarian cancer	0.000185	0.000768	CcSEcCtD
Esmolol—Convulsion—Epirubicin—ovarian cancer	0.000185	0.000766	CcSEcCtD
Esmolol—Pruritus—Docetaxel—ovarian cancer	0.000183	0.000757	CcSEcCtD
Esmolol—Chest pain—Epirubicin—ovarian cancer	0.000182	0.000753	CcSEcCtD
Esmolol—Agitation—Doxorubicin—ovarian cancer	0.000182	0.000752	CcSEcCtD
Esmolol—Anxiety—Epirubicin—ovarian cancer	0.000181	0.00075	CcSEcCtD
Esmolol—Nausea—Paclitaxel—ovarian cancer	0.000181	0.00075	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000181	0.000748	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—ovarian cancer	0.000178	0.000736	CcSEcCtD
Esmolol—Syncope—Doxorubicin—ovarian cancer	0.000177	0.000734	CcSEcCtD
Esmolol—Confusional state—Epirubicin—ovarian cancer	0.000176	0.000728	CcSEcCtD
Esmolol—Oedema—Epirubicin—ovarian cancer	0.000174	0.000722	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000174	0.000719	CcSEcCtD
Esmolol—Shock—Epirubicin—ovarian cancer	0.000171	0.00071	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—ovarian cancer	0.000171	0.000709	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—ovarian cancer	0.000171	0.000708	CcSEcCtD
Esmolol—Dizziness—Docetaxel—ovarian cancer	0.000171	0.000708	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—ovarian cancer	0.000169	0.000701	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000168	0.000698	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—ovarian cancer	0.000168	0.000697	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—ovarian cancer	0.000168	0.000694	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000167	0.000692	CcSEcCtD
Esmolol—Anorexia—Epirubicin—ovarian cancer	0.000166	0.000688	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—ovarian cancer	0.000164	0.000681	CcSEcCtD
Esmolol—Vomiting—Docetaxel—ovarian cancer	0.000164	0.00068	CcSEcCtD
Esmolol—Hypotension—Epirubicin—ovarian cancer	0.000163	0.000675	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—ovarian cancer	0.000163	0.000673	CcSEcCtD
Esmolol—Headache—Docetaxel—ovarian cancer	0.000162	0.00067	CcSEcCtD
Esmolol—Oedema—Doxorubicin—ovarian cancer	0.000161	0.000668	CcSEcCtD
Esmolol—Shock—Doxorubicin—ovarian cancer	0.000159	0.000657	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000158	0.000655	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—ovarian cancer	0.000157	0.000649	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—ovarian cancer	0.000156	0.000648	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000156	0.000646	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—ovarian cancer	0.000155	0.000644	CcSEcCtD
Esmolol—Somnolence—Epirubicin—ovarian cancer	0.000155	0.000642	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—ovarian cancer	0.000154	0.000637	CcSEcCtD
Esmolol—Nausea—Docetaxel—ovarian cancer	0.000153	0.000636	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—ovarian cancer	0.000153	0.000635	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—ovarian cancer	0.000151	0.000627	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—ovarian cancer	0.000151	0.000624	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00015	0.000623	CcSEcCtD
Esmolol—Fatigue—Epirubicin—ovarian cancer	0.00015	0.000622	CcSEcCtD
Esmolol—Pain—Epirubicin—ovarian cancer	0.000149	0.000617	CcSEcCtD
Esmolol—Constipation—Epirubicin—ovarian cancer	0.000149	0.000617	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—ovarian cancer	0.000145	0.0006	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—ovarian cancer	0.000144	0.000595	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—ovarian cancer	0.000144	0.000595	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—ovarian cancer	0.000143	0.000594	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—ovarian cancer	0.000142	0.000588	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—ovarian cancer	0.00014	0.000581	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000139	0.000577	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—ovarian cancer	0.000139	0.000576	CcSEcCtD
Esmolol—Urticaria—Epirubicin—ovarian cancer	0.000138	0.000573	CcSEcCtD
Esmolol—Constipation—Doxorubicin—ovarian cancer	0.000138	0.000571	CcSEcCtD
Esmolol—Pain—Doxorubicin—ovarian cancer	0.000138	0.000571	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—ovarian cancer	0.000138	0.000571	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000133	0.00055	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—ovarian cancer	0.000128	0.000531	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—ovarian cancer	0.000127	0.000528	CcSEcCtD
Esmolol—Asthenia—Epirubicin—ovarian cancer	0.000125	0.000518	CcSEcCtD
Esmolol—Pruritus—Epirubicin—ovarian cancer	0.000123	0.000511	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—ovarian cancer	0.000116	0.000479	CcSEcCtD
Esmolol—Dizziness—Epirubicin—ovarian cancer	0.000115	0.000477	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—ovarian cancer	0.000114	0.000473	CcSEcCtD
Esmolol—Vomiting—Epirubicin—ovarian cancer	0.000111	0.000459	CcSEcCtD
Esmolol—Headache—Epirubicin—ovarian cancer	0.000109	0.000452	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—ovarian cancer	0.000107	0.000442	CcSEcCtD
Esmolol—Nausea—Epirubicin—ovarian cancer	0.000103	0.000429	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—ovarian cancer	0.000103	0.000425	CcSEcCtD
Esmolol—Headache—Doxorubicin—ovarian cancer	0.000101	0.000418	CcSEcCtD
Esmolol—Nausea—Doxorubicin—ovarian cancer	9.58e-05	0.000397	CcSEcCtD
